Skip to Main Content
The first stop for professional medicines advice

Aflibercept

2 results

Applied filters
Registration required

The licence and supporting evidence for aflibercept biosimilars

26 September 2025Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.

Preparing to use aflibercept 2mg biosimilar

4 July 2025Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.